BMJ Open publishes all reviews undertaken for accepted manuscripts. Reviewers are asked to complete a checklist review form (http://bmjopen.bmj.com/site/about/resources/checklist.pdf) and are provided with free text boxes to elaborate on their assessment. These free text comments are reproduced below.
Dainelli et al. report on a dietary approach to blood pressure lowering in China. In many parts of China, dietary sodium consumption is quite high, and most sodium is added during cooking, High sodium consumption may be a driver of increased cardiovascular disease risk. Supplemental potassium, whether via high potassium foods or as a supplement, has been demonstrated to lower blood pressure modestly in randomized trials. Past studies have examined "salt substitute" formulations that aim to reduce sodium consumption and increase potassium consumption simultaneously. Another dietary approach to blood pressure lowering is pure potassium supplementation. Dainelli et al. studied the potential downstream health benefits and cost effectiveness of a low-cost, daily consumption of potassium fortified milk powder for blood pressure lowering. This is a study of an intervention that may be a low cost, populationbased intervention to lower blood pressure and cardiovascular disease in China. Generally, the paper is well written and transparent about the model inputs and structure are transparently reported. Inclusion of the EVEREST statement builds confidence in the rigor of the approach. The study conforms to most standards for economic analysis and computer simulation modeling. I see several gaps in the paper that should be addressed by the authors: 1) Abstract results should report quantitative results, not just "it was cost-effective" 2) Methods content is mixed in with the Results. The model structure and input parameters (pages 4-7, lines 117 to 154, belong in the Methods section or in a technical appendix.
3) Study population is not defined. I assume this is a simple Markov model without a defined population size? I assume that the entire adult population is simulated. Is the average potassium consumption applied to every person? Because dietary patterns vary substantially geographically and by age in China, at least exploring a range of baseline potassium intake and baseline BP is important. Baseline potassium intake and baseline BP both determine the clinical effectiveness of a potassium supplement. These exploratory analyses have implications for which geographic areas and which populations might benefit most.
4) The proportion of Chinese adults who consume milk now is relatively small (9% of adults). Please state if the premise is that potassium fortified milk would be replaced in current milk consumers or if the idea is to expand milk consumption to the whole population or to those with hypertension only. 5) Limitations should include no information on sodium intake and any effect of fortified milk consumption on sodium consumption. Also no information on the impact of increased caloric intake due to powdered milk consumption in adults not currently consuming milk. I.e., unintended consequences not fully considered.
6) There is a lot of information about the costs of hypertension screening and treatment. It is not clear how this information is integrated into the study. Was blood pressure and hypertension status modeled somehow? Was the impact of preventing hypertension diagnosis part of this study? How was that part modeled, specifically? 7) Tornado diagram is not clearly labeled. It appears that a number of parameters are examined in the one-way sensitivity analyses, the authors should add baseline BP, baseline potassium ranges as mentioned above, as well as the effectiveness range (that is also modeled in the PSA scatterplots). It is a limitation that only selected parameters were entered into the PSA. 8) In the Discussion, when comparing effectiveness of "functional foods" in Europe vs. China, it should be pointed out that European and North American populations consume a lot of processed food outside the home. Past and current Chinese cultural practices include an emphasis on home cooked food and thus Chinese populations may gain more effects from targeted dietary interventions that include foods consumed at home. 9) There is a prior modeling study that included study of salt substitutes (which include both sodium and potassium along with magnesium). That study should be cited: Following the melamine contamination problem, there has also been some reduction in popularity of locally produced milk powders. Given that potassium fortification generally also makes foods taste quite bitter, from a public health perspective there may well be issues for uptake of the fortified product which would substantially influence effectiveness/compliance with such an intervention. Some discussion of these potential barriers to uptake need to be included in the limitations.
VERSION 1 -AUTHOR RESPONSE
Reviewer: 1 Andrew Moran Columbia University, USA Please state any competing interests or state "None declared": None declared
Please leave your comments for the authors below Comments for the authors Dainelli et al. report on a dietary approach to blood pressure lowering in China. In many parts of China, dietary sodium consumption is quite high, and most sodium is added during cooking. High sodium consumption may be a driver of increased cardiovascular disease risk. Supplemental potassium, whether via high potassium foods or as a supplement, has been demonstrated to lower blood pressure modestly in randomized trials. Past studies have examined "salt substitute" formulations that aim to reduce sodium consumption and increase potassium consumption simultaneously. Another dietary approach to blood pressure lowering is pure potassium supplementation. Dainelli et al. studied the potential downstream health benefits and cost effectiveness of a low-cost, daily consumption of potassium fortified milk powder for blood pressure lowering.
This is a study of an intervention that may be a low cost, population-based intervention to lower blood pressure and cardiovascular disease in China. Generally, the paper is well written and transparent about the model inputs and structure are transparently reported. Inclusion of the EVEREST statement builds confidence in the rigor of the approach. The study conforms to most standards for economic analysis and computer simulation modeling.
I see several gaps in the paper that should be addressed by the authors: 1) Abstract results should report quantitative results, not just "it was cost-effective"
Answer Added in the abstract (lines 32-36).
2) Methods content is mixed in with the Results. The model structure and input parameters (pages 4-7, lines 117 to 154) belong in the Methods section or in a technical appendix. Answer Indicated lines moved in the method section (now 116-152).
3) Study population is not defined. I assume this is a simple Markov model without a defined population size? I assume that the entire adult population is simulated. The proportion of Chinese adults who consume milk now is relatively small (9% of adults). Please state if the premise is that potassium fortified milk would be replaced in current milk consumers or if the idea is to expand milk consumption to the whole population or to those with hypertension only. Answer The population of interest consists of the 8.67% of the 50-79 year olds who regularly consume milk in China. The fortified milk should be replaced in current milk consumers, both hypertensive and not hypertensive. Further research should be carried out to see if it is cost-effective to expand the fortified milk consumption to the rest of the population (abstract lines 19 and 39 + lines 75-76).
4) Also no information on the impact of increased caloric intake due to powdered milk consumption in adults not currently consuming milk. I.e., unintended consequences not fully considered. Answer Since the intervention is targeting people who already consume milk, there would be no impact on the total caloric intake (line 283).
5) Limitations should include no information on sodium intake and any effect of fortified milk consumption on sodium consumption. Answer Limitations added (lines 233-238).
6) There is a lot of information about the costs of hypertension screening and treatment. It is not clear how this information is integrated into the study. Was blood pressure and hypertension status modeled somehow? Was the impact of preventing hypertension diagnosis part of this study? How was that part modeled, specifically? Answer To be conservative, the healthcare cost of hypertension screening and treatment was added only in the model branch "Chronic CVD" (not in "Well" nor "Death") on the assumption that a person who had an event (either stroke or MI) will take, in addition to their specific treatments, drugs and schedule yearly checkups to prevent another event. The fact that people in the "Well" branch do not have this cost has been added in the limitations (lines 232-233). For the rest of the answer, please check the point below.
7) Is the average potassium consumption applied to every person? Because dietary patterns vary substantially geographically and by age in China, at least exploring a range of baseline potassium intake and baseline BP is important. Baseline potassium intake and baseline BP both determine the clinical effectiveness of a potassium supplement. These exploratory analyses have implications for which geographic areas and which populations might benefit most. Answer The average consumption is applied to every person in the considered population (50-79 year olds who regularly drink milk). The range of baseline potassium intake of Chinese population is shown in the added Figure 1 . However, in their subgroup analyses, Aburto et al. (2013) showed that, regardless of baseline potassium intake, there is a comparable reduction in blood pressure when potassium intake is increased. For example, the reduction in systolic blood pressure reached 3.9 mmHg (95%CI: 0.7-7.0), 3.4 mmHg (95%CI: 1.3-5.5) and 4.1 mmHg (95%CI: 1.9-6.2) for baseline potassium intake of <50 mmol/day, 50-80 mmol/day and >80 mmol/day, respectively. So one can assume that this is likely the case for the Chinese population. In order to estimate the effect of an additional potassium intake on BP, we relied on one human intervention study conducted in China, the only to our knowledge, with a heterogeneous population (normotensive, pre-hypertensive and hypertensive). In that study, the baseline systolic BP is 130-159 mmHg, which is consistent with other reported figures from the literature for a similar age range of age (Wang et al., 2016) . Differently from the baseline potassium intake, it is well accepted that the reduction in the blood pressure is influenced by the blood pressure status at baseline, as also shown by the same authors (Aburto et al., 2013), with much larger effects observed in hypertensive than in non-hypertensive individuals. Interestingly, potassium has also been shown to exert a dose-dependent inhibitory effect on sodium sensitivity (an independent risk factor for cardiovascular disease) in normotensive individuals (Morris et al., 1999) . Also, blood pressure may be significantly lowered in normotensive subjects with low dietary intake of potassium (Sacks et al., 1998) . We are therefore confident that both normotensive and hypertensive would equally benefit from a potassium supplementation. Moreover, it appears that the reduction in blood pressure is increased in older individuals (vs. younger ones), for example: 3.30mmHg for age >45 years vs 0.01mmHg for age <45 years) (Geleijnse et al., 2003) , which incidentally is most pertinent for the age range of the Chinese population chosen in this study.
In other words, we may expect to see greater effects of potassium on SBP when starting from different BP baseline, but, unfortunately, no other study has been conducted with such a small amount of potassium like ours (+700g/d), therefore we could not model the provincial level variation impact. Acknowledging these limitations, we took uncertainty into consideration through an extended sensitivity analysis, to model which would be the effect at different level of effectiveness on SBP (100%; 75%, 50%, 25% and 10%). Overall, we think that, by this approach, we have captured at best the different scenarios that would apply to normotensive, pre-hypertensive and hypertensive altogether (lines 191-216 It appears that a number of parameters are examined in the one-way sensitivity analyses, the authors should add baseline BP, baseline potassium ranges as mentioned above, as well as the effectiveness range (that is also modeled in the PSA scatterplots). It is a limitation that only selected parameters were entered into the PSA. Answer As far as concerns baseline BP and potassium ranges please see the answer above. Different tornado diagrams have been generated according to the levels of effectiveness (as modeled in the PSA). PSA now contains all the input parameters, including utilities and resources used (lines 170-182).
9) In the Discussion, when comparing effectiveness of "functional foods" in Europe vs. China, it should be pointed out that European and North American populations consume a lot of processed food outside the home. Past and current Chinese cultural practices include an emphasis on home cooked food and thus Chinese populations may gain more effects from targeted dietary interventions that include foods consumed at home. There is a prior modeling study that included study of salt substitutes (which include both sodium and potassium along with magnesium). That study should be 
Alice Owen Monash University, Australia Please state any competing interests or state "None declared": None declared
Please leave your comments for the authors below This is an interesting and well-written paper applying epidemiologically modeling to examine the potential effectiveness and cost effectiveness of potassium-fortified milk powder to reduce cardiovascular events in a Chinese population. 2) Given that potassium fortification generally also makes foods taste quite bitter, from a public health perspective there may well be issues for uptake of the fortified product which would substantially influence effectiveness/compliance with such an intervention. Some discussion of these potential barriers to uptake need to be included in the limitations. Answer The amount of potassium added to fortify is the maximum that the consumers showed to tolerate during consumers tastes. Going over that quantity, as you have correctly highlighted, would mean to risk to do not have the full compliance (lines 225-228).
VERSION 2 -REVIEW

REVIEWER
Andrew Moran
Columbia University, USA REVIEW RETURNED 01-Jul-2017
GENERAL COMMENTS
The authors responded adequately to the reviews. Given that this modelling is not underpinned by the results of CVD outcome trials of potassium-fortified milk in this population setting, (ie the effects on CVD events have been inferred from BP changes seen in a short-term intervention trial of a potassium chloride tablet, rather than a fortified food product) the authors may wish to be more circumspect in their final conclusion.
REVIEWER
The authors have satisfactorily addressed the comments raised in the previous review.
VERSION 2 -AUTHOR RESPONSE
Reviewer: 2 Alice Owen Monash University, Australia Please state any competing interests or state "None declared": None declared
Please leave your comments for the authors below.
3) The abstract states: "Together with other preventive interventions, the consumption of a milk powder fortified with potassium could represent a cost-effective strategy to attenuate the rapid rise in cardiovascular burden among the 50-79 year olds who regularly consume milk in China." This could be interpreted as meaning that Chinese adults aged 50-79y who regularly consume milk have experienced a rise in CVD burden that differs to non-milk-drinkers (although I suspect that this is not what the authors intended). What is known about CVD risk or burden in those of that age who regularly drink milk compared to those who do not? If anything is known specifically about CVD risk in Chinese milk drinkers compared to others of that age group then it should be stated and referenced, otherwise included as a limitation.
Answer Thanks for your comment. This point has been added to the limitations (lines 238-39).
4) Given that this modelling is not underpinned by the results of CVD outcome trials of potassiumfortified milk in this population setting, (ie the effects on CVD events have been inferred from BP changes seen in a short-term intervention trial of a potassium chloride tablet, rather than a fortified food product) the authors may wish to be more circumspect in their final conclusion.
Answer Thanks for your comment. We rephrased the conclusion (lines 311-315): "Together with other preventive interventions, the consumption of a milk powder fortified with potassium could represent a cost-effective strategy to attenuate the rapid rise in cardiovascular burden among the 50-79 year olds in China. This strategy could be especially easy to implement in those already having regular dairy consumption, and even encouraged in those with low dairy product intake."
5) The authors have satisfactorily addressed the comments raised in the previous review. Answer Thanks a lot!
